Showing results (41-50 of 96) with videos related to
Sort By:
Pageof 10
Journal of the National Cancer Institute|April 19, 2007
Potential drug interactions and duplicate prescriptions among cancer patientsRachel P Riechelmann, Ian F Tannock, Lisa Wang, et al.Journal of Pain and Symptom Management|February 5, 2008
Potential drug interactions in cancer patients receiving supportive care exclusivelyRachel P Riechelmann, Camilla Zimmermann, Sheray N Chin, et al.Cancer Treatment Reviews|April 30, 2017
Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic reviewDaniel M Girardi, Andrea C B Silva, Juliana Florinda M Rêgo, et al.Rare Tumors|November 2, 2013
Combination of Capecitabine and Oxaliplatin is an Effective Treatment Option for Advanced Neuroendocrine TumorsRenata Ferrarotto, Laura Testa, Rachel P Riechelmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncologyGiovanni M Bariani, Anezka C R de Celis Ferrari, Paulo M Hoff, et al.Ecancermedicalscience|March 5, 2024
Loss of CDX2 and high COX2 (PTGS2) expression in metastatic colorectal cancerÁlvaro M C Caldas, Warley A Nunes, Rodrigo Taboada, et al.Ecancermedicalscience|October 6, 2015
Living better or living longer? Perceptions of patients and health care professionals in oncologyDiego de Araujo Toloi, Gabriela Critchi, Andrea Mangabeira, et al.American Journal of Clinical Oncology|January 10, 2014
Sample Size Calculation in Oncology Trials: Quality of Reporting and Implications for Clinical Cancer ResearchGiovanni M Bariani, Anezka C R de Celis Ferrari, Maristela Precivale, et al.American Journal of Clinical Oncology|April 9, 2008
Sorafenib for metastatic renal cancer: the Princess Margaret experienceRachel P Riechelmann, Soo Chin, Lisa Wang, et al.Ecancermedicalscience|January 21, 2017
Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysisKarla T Souza, Allan Al Pereira, Raphael L Araujo, et al.Pageof 10